期刊： DISEASES OF THE ESOPHAGUS, 2022; 35 (12)
Aim The role of triamcinolone acetonide (TA) in the prevention of esophageal stricture is not well established. This meta-analysis aimed to evaluate i......
期刊： DISEASES OF THE ESOPHAGUS, 2022; 35 (9)
The effects of preoperative sarcopenia on postoperative complications and survival outcomes of patients undergoing esophageal cancer resection are con......
期刊： DISEASES OF THE ESOPHAGUS, 2022; 35 (8)
Background: To date, the ideal endoscopic knife for peroral endoscopic myotomy (POEM) with good performance and cost-effectiveness is still under inve......
期刊： DISEASES OF THE ESOPHAGUS, 2022; 35 (10)
Background and purpose: This meta-analysis assesses the surgical outcomes between robot-assisted minimally-invasive McKeown esophagectomy and conventi......
期刊： DISEASES OF THE ESOPHAGUS, 2022; 35 (9)
This study investigated whether neoadjuvant therapies, such as neoadjuvant chemoradiotherapy (NCRT), neoadjuvant chemotherapy (NCT), and neoadjuvant r......
期刊： DISEASES OF THE ESOPHAGUS, 2022; 35 (3)
Postoperative enteral nutrition has been widely implemented in esophageal cancer, but the efficacy and safety of preoperative nutrition, particularly ......
期刊： DISEASES OF THE ESOPHAGUS, 2022; 35 (4)
Background Heterotopic gastric mucosa in the upper esophagus (HGMUE) is reported to be related to gastroesophageal reflux disease (GERD). This study i......
期刊： DISEASES OF THE ESOPHAGUS, 2022; 35 (7)
Background Mediastinal lymphadenectomy is of great importance during esophagectomy for esophageal squamous cell carcinoma. However, recurrent laryngea......
期刊： DISEASES OF THE ESOPHAGUS, 2022; 35 (2)
This study aimed to demonstrate the learning curve of robot-assisted minimally invasive esophagectomy (RAMIE). A retrospective analysis of the first 1......
期刊： DISEASES OF THE ESOPHAGUS, 2022; 35 (1)
Currently, the reports on esophageal endoscopic submucosal dissection (ESD) assisted by traction with a snare are rare. Because a snare is a commonly ......
期刊： DISEASES OF THE ESOPHAGUS, 2022; 35 (3)
Background Esophagectomy and definitive chemoradiotherapy are commonly used in the treatment of stage I esophageal cancer (EC). The present study aims......
期刊： DISEASES OF THE ESOPHAGUS, 2022; 35 (11)
Immune checkpoint inhibitors (ICIs) have shown a powerful benefit in the neoadjuvant therapy for esophageal cancer, but evidence for its safety and ef......
期刊： DISEASES OF THE ESOPHAGUS, 2022; 35 (8)
To evaluate the effects of two different reconstruction routes (the posterior mediastinal route (PR) and the retrosternal route (RR)) on the surgical ......
期刊： DISEASES OF THE ESOPHAGUS, 2021; 34 (2)
Although robotic techniques have been used for oesophagectomy for many years, whether robotassisted minimally invasive oesophagectomy (RAMIE) can actu......
期刊： DISEASES OF THE ESOPHAGUS, 2021; 34 (6)
There is growing focus on the relationship between surgical start time and postoperative outcomes. However, the extent to which the operation start ti......
